Methylation and Related Anogenital HPV Cancers

甲基化和相关的肛门生殖器 HPV 癌症

基本信息

  • 批准号:
    7927783
  • 负责人:
  • 金额:
    $ 14.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-02-01 至 2011-09-29
  • 项目状态:
    已结题

项目摘要

Anal cancer is an emerging health crisis for homosexual men, especially within the context of human mmunodeficiency virus (HIV) infection. Like invasive cervical cancer, intra-anal cancers are largely attributable to chronic, high-risk human papillomavirus (HPV) infections. These infections and their associated low- and high-grade anal intraepithelial neoplasias (AIM) are common for men with a history of receptive anal intercourse. Though the prevalence of anal dysplasia is high, malignancy is a relatively rare occurrence. Domestically, there is no consensus for standards of care, and the outcome of treatment algorithms is largely unsatisfactory. There is an urgent need to identify key events in the underlying natural history of disease, which will enable clinicians to determine which individuals need immediate treatment or can remain under careful surveillance. More sensitive biomarkersthat can discriminate between men likely to progress from those that do not will allow better clinical algorithms to be tested. In the long term, these strategies will reduce morbidity and mortality and diminish the population's burden of disease. Methylation is an adaptive cellular process that hinders transcription of foreign DMA by making viral genomes less accessible to host-cell transcription factors and enzymes. Our recent studies suggest methylation of HPV genomes may be an epigenetic determinant, responsible for promoting latent infection and clinical disease progression. This investigation focuses on two aims using epidemiological methods and molecular biology techniques. First, we will determine whether previously observed relationships between methylation of HPV16 genomes and disease state are observable in 91 HIV/HPV16 coinfected men that have been evaluated for AIM. Second, using longitudinally-collected clinical samples and controlling for the effect of time-dependent covariates, we will determine whether particular baseline patterns of methylation in HPV16 genomes predict methylation patterns overtime in three high-risk HPVs. PUBLIC HEALTH STATEMENT: The findings from this study will improve the public's health by improving anal cancer screening accuracy through the identification of reliable biomarkers, to ultimately prevent premature death.
肛门癌是一个新兴的健康危机的同性恋男子,特别是在人类的背景下, 免疫缺陷病毒(HIV)感染。与浸润性宫颈癌一样,肛门内癌主要是 可归因于慢性、高风险的人乳头瘤病毒(HPV)感染。这些感染及其 相关的低度和高度肛门上皮内瘤变(AIM)在有以下病史的男性中很常见: 接受性肛交虽然肛门发育不良的患病率很高,但恶性肿瘤相对罕见。 发生。在国内,对治疗标准和治疗结果没有共识 算法在很大程度上不能令人满意。迫切需要查明潜在自然灾害中的关键事件, 病史,这将使临床医生能够确定哪些人需要立即治疗, 可以继续受到严密监视更敏感的生物标志物,可以区分男性, 从那些不允许的进展将允许更好的临床算法被测试。从长远来看,这些 这些战略将降低发病率和死亡率,减轻人口的疾病负担。 甲基化是一种适应性细胞过程,通过使病毒DNA甲基化来阻碍外源DNA的转录。 宿主细胞转录因子和酶不易进入的基因组。我们最近的研究表明 HPV基因组甲基化可能是一种表观遗传决定因素,负责促进潜伏感染 和临床疾病进展。这项调查的重点是两个目标,使用流行病学方法, 分子生物学技术首先,我们将确定先前观察到的 在91名HIV/HPV 16共感染男性中观察到HPV 16基因组甲基化和疾病状态, 已被评估为AIM。第二,使用临床采集的样本, 时间依赖性协变量的影响,我们将确定是否特定的基线模式的甲基化, HPV 16基因组预测三种高危HPV随时间推移的甲基化模式 公共卫生声明:这项研究的结果将通过以下方式改善公众健康: 通过鉴定可靠的生物标志物来提高肛门癌筛查的准确性, 防止过早死亡。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOROTHY J. WILEY其他文献

DOROTHY J. WILEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOROTHY J. WILEY', 18)}}的其他基金

Improving screening tools to better predict high-grade anal dysplasia for MSM
改进筛查工具以更好地预测 MSM 的重度肛门发育不良
  • 批准号:
    8885483
  • 财政年份:
    2013
  • 资助金额:
    $ 14.85万
  • 项目类别:
Improving screening tools to better predict high-grade anal dysplasia for MSM
改进筛查工具以更好地预测 MSM 的重度肛门发育不良
  • 批准号:
    8506413
  • 财政年份:
    2013
  • 资助金额:
    $ 14.85万
  • 项目类别:
Improving screening tools to better predict high-grade anal dysplasia for MSM
改进筛查工具以更好地预测 MSM 的重度肛门发育不良
  • 批准号:
    9079261
  • 财政年份:
    2013
  • 资助金额:
    $ 14.85万
  • 项目类别:
Improving screening tools to better predict high-grade anal dysplasia for MSM
改进筛查工具以更好地预测 MSM 的重度肛门发育不良
  • 批准号:
    8730582
  • 财政年份:
    2013
  • 资助金额:
    $ 14.85万
  • 项目类别:
PHASE II CLINICAL STUDIES OF CHEMOPREVENTION AGENTS - WORKSTATEMENT 80: AN EX
化学预防药物的 II 期临床研究 - 工作声明 80:AN EX
  • 批准号:
    7606788
  • 财政年份:
    2007
  • 资助金额:
    $ 14.85万
  • 项目类别:
Methylation and Related Anogenital HPV Cancers
甲基化和相关的肛门生殖器 HPV 癌症
  • 批准号:
    7348432
  • 财政年份:
    2007
  • 资助金额:
    $ 14.85万
  • 项目类别:
Methylation and Related Anogenital HPV Cancers
甲基化和相关的肛门生殖器 HPV 癌症
  • 批准号:
    7231117
  • 财政年份:
    2007
  • 资助金额:
    $ 14.85万
  • 项目类别:

相似海外基金

SGN-00101 IN HIGH-GRADE ANAL INTRAEPITHELIAL NEOPLASIA (AIN) IN HIV+ INDIVIDUALS
SGN-00101 在 HIV 个体的高级别肛门上皮内瘤变 (AIN) 中的应用
  • 批准号:
    7202634
  • 财政年份:
    2005
  • 资助金额:
    $ 14.85万
  • 项目类别:
SGN-00101 IN HIGH-GRADE ANAL INTRAEPITHELIAL NEOPLASIA (AIN) IN HIV+ INDIVIDUALS
SGN-00101 在 HIV 个体的高级别肛门上皮内瘤变 (AIN) 中的应用
  • 批准号:
    6972291
  • 财政年份:
    2004
  • 资助金额:
    $ 14.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了